Publications

Publications

  1. Smith, JJ, Chatila, WK, Sanchez-Vega, F, Datta, J, Connell, LC, Szeglin, BC et al.. Genomic stratification beyond Ras/B-Raf in colorectal liver metastasis patients treated with hepatic arterial infusion. Cancer Med. 2019; :. doi: 10.1002/cam4.2415. PubMed PMID:31503397 .
  2. Ntiamoah, P, Monu, NR, Abdulkareem, FB, Adeniji, KA, Obafunwa, JO, Komolafe, AO et al.. Pathology Services in Nigeria: Cross-Sectional Survey Results From Three Cancer Consortia. J Glob Oncol. 2019;5 :1-9. doi: 10.1200/JGO.19.00138. PubMed PMID:31479341 .
  3. Ayabe, RI, Narayan, RR, Ruff, SM, Wach, MM, Lo, W, Nierop, PMH et al.. Disease-free interval and tumor functional status can be used to select patients for resection/ablation of liver metastases from adrenocortical carcinoma: insights from a multi-institutional study. HPB (Oxford). 2019; :. doi: 10.1016/j.hpb.2019.07.002. PubMed PMID:31447392 .
  4. Buisman, FE, Galjart, B, van der Stok, EP, Balachandran, VP, Boerner, T, Drebin, JA et al.. Recurrence Patterns After Resection of Colorectal Liver Metastasis are Modified by Perioperative Systemic Chemotherapy. World J Surg. 2019; :. doi: 10.1007/s00268-019-05121-9. PubMed PMID:31410513 .
  5. Knapp, GC, Sharma, A, Olopade, B, Alatise, OI, Olasehinde, O, Arije, OO et al.. An Exploratory Analysis of Fecal Immunochemical Test Performance for Colorectal Cancer Screening in Nigeria. World J Surg. 2019; :. doi: 10.1007/s00268-019-05100-0. PubMed PMID:31407091 .
  6. Yamashita, R, Perrin, T, Chakraborty, J, Chou, JF, Horvat, N, Koszalka, MA et al.. Radiomic feature reproducibility in contrast-enhanced CT of the pancreas is affected by variabilities in scan parameters and manual segmentation. Eur Radiol. 2019; :. doi: 10.1007/s00330-019-06381-8. PubMed PMID:31392481 .
  7. Saldia, A, Olson, SH, Nunes, P, Liang, X, Samson, ML, Salo-Mullen, E et al.. Outcome of Pancreatic Cancer Surveillance Among High-Risk Individuals Tested for Germline Mutations in and . Cancer Prev Res (Phila). 2019;12 (9):599-608. doi: 10.1158/1940-6207.CAPR-18-0272. PubMed PMID:31337648 PubMed Central PMC6726560.
  8. Khalil, DN, Suek, N, Campesato, LF, Budhu, S, Redmond, D, Samstein, RM et al.. In situ vaccination with defined factors overcomes T cell exhaustion in distant tumors. J. Clin. Invest. 2019;129 (8):3435-3447. doi: 10.1172/JCI128562. PubMed PMID:31329159 PubMed Central PMC6668692.
  9. Springer, S, Masica, DL, Dal Molin, M, Douville, C, Thoburn, CJ, Afsari, B et al.. A multimodality test to guide the management of patients with a pancreatic cyst. Sci Transl Med. 2019;11 (501):. doi: 10.1126/scitranslmed.aav4772. PubMed PMID:31316009 .
  10. Golia Pernicka, JS, Gagniere, J, Chakraborty, J, Yamashita, R, Nardo, L, Creasy, JM et al.. Radiomics-based prediction of microsatellite instability in colorectal cancer at initial computed tomography evaluation. Abdom Radiol (NY). 2019; :. doi: 10.1007/s00261-019-02117-w. PubMed PMID:31250180 .
  11. Attiyeh, MA, Chakraborty, J, McIntyre, CA, Kappagantula, R, Chou, Y, Askan, G et al.. CT radiomics associations with genotype and stromal content in pancreatic ductal adenocarcinoma. Abdom Radiol (NY). 2019;44 (9):3148-3157. doi: 10.1007/s00261-019-02112-1. PubMed PMID:31243486 PubMed Central PMC6692205.
  12. McIntyre, CA, Pulvirenti, A, Lawrence, SA, Seier, K, Gonen, M, Balachandran, VP et al.. Neutrophil-to-Lymphocyte Ratio as a Predictor of Invasive Carcinoma in Patients With Intraductal Papillary Mucinous Neoplasms of the Pancreas. Pancreas. 2019;48 (6):832-836. doi: 10.1097/MPA.0000000000001342. PubMed PMID:31210665 .
  13. Knapp, GC, Alatise, OI, Olasehinde, OO, Adeyeye, A, Ayandipo, OO, Weiser, MR et al.. Is Colorectal Cancer Screening Appropriate in Nigeria?. J Glob Oncol. 2019;5 :1-10. doi: 10.1200/JGO.19.00035. PubMed PMID:31170018 PubMed Central PMC6613663.
  14. Deng, L, Ismond, K, Liu, Z, Constable, J, Wang, H, Alatise, OI et al.. Urinary Metabolomics to Identify a Unique Biomarker Panel for Detecting Colorectal Cancer: A Multicenter Study. Cancer Epidemiol. Biomarkers Prev. 2019;28 (8):1283-1291. doi: 10.1158/1055-9965.EPI-18-1291. PubMed PMID:31151939 PubMed Central PMC6677589.
  15. Wang, T, Drill, E, Vakiani, E, Pak, LM, Boerner, T, Askan, G et al.. Distinct histomorphological features are associated with IDH1 mutation in intrahepatic cholangiocarcinoma. Hum. Pathol. 2019;91 :19-25. doi: 10.1016/j.humpath.2019.05.002. PubMed PMID:31121195 PubMed Central PMC6744317.
  16. Doussot, A, Jarnagin, WR, Azoulay, D, Heyd, B. Improving actual survival after hepatectomy for intrahepatic cholangiocarcinoma-still a long way to go. Hepatobiliary Surg Nutr. 2019;8 (2):161-163. doi: 10.21037/hbsn.2018.11.21. PubMed PMID:31098368 PubMed Central PMC6503243.
  17. Olasehinde, O, Arije, O, Wuraola, FO, Samson, M, Olajide, O, Alabi, T et al.. Life Without a Breast: Exploring the Experiences of Young Nigerian Women After Mastectomy for Breast Cancer. J Glob Oncol. 2019;5 :1-6. doi: 10.1200/JGO.18.00248. PubMed PMID:31095453 PubMed Central PMC6550027.
  18. Creasy, JM, Goldman, DA, Gonen, M, Dudeja, V, O'Reilly, EM, Abou-Alfa, GK et al.. Evolution of surgical management of gallbladder carcinoma and impact on outcome: results from two decades at a single-institution. HPB (Oxford). 2019; :. doi: 10.1016/j.hpb.2019.03.370. PubMed PMID:31027875 .
  19. Narayan, RR, Kingham, TP. ASO Author Reflections: Perioperative Genomic Profiles and Prognosis of Peripheral and Perihepatic Circulating Tumor DNA in Patients with Colorectal Liver Metastases. Ann. Surg. Oncol. 2019; :. doi: 10.1245/s10434-019-07360-5. PubMed PMID:30989499 .
  20. Wang, T, Askan, G, Adsay, V, Allen, P, Jarnagin, WR, Memis, B et al.. Intraductal Oncocytic Papillary Neoplasms: Clinical-Pathologic Characterization of 24 Cases, With An Emphasis on Associated Invasive Carcinomas. Am. J. Surg. Pathol. 2019;43 (5):656-661. doi: 10.1097/PAS.0000000000001226. PubMed PMID:30986801 PubMed Central PMC6467507.
Search PubMed